Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adverse Drug Reactions
New data from University Hospital, Department of Rheumatology illuminate research in adverse drug reactions
May 11th, 2008
New investigation results, 'Hepatotoxicity associated with sulfasalazine in inflammatory arthritis: A case series from a local surveillance of serious adverse events,' are detailed in a study published in BMC Musculoskeletal Disorders. "Spontaneous reporting systems for adverse drug reactions (ADRs) are handicapped by under-reporting and limited detail on individual cases. We report an investigation from a local surveillance for serious adverse drug reactions associated with disease modifying anti-rheumatic drugs that was triggered by the occurrence of liver failure in two of our patients," investigators in Birmingham, the United Kingdom report. "Serious ADR...
Source: Pharma Investments, Ventures & Law Weekly (2008-05-11)
|
